Skip to main content
SpringerLink
Log in

Community pharmacists’ knowledge of diabetes management during Ramadan in Egypt

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background Although Muslim diabetic patients may be aware of their religious exemption from fasting, many still fast and adjust their medication regimens accordingly. Pharmacists have a significant potential to identify and prevent harm from medication misuse in Ramadan. Objectives This study examines Egyptian pharmacists’ knowledge regarding management of diabetes during Ramadan. It also explores pharmacists’ willingness to attend a 1 day workshop on medication regimen adjustment during Ramadan. Setting Community pharmacies throughout Alexandria, Egypt. Methods A cross-sectional study using a pretested self-administered survey was conducted among a random sample of community pharmacists. The survey included three knowledge questions relevant to counseling diabetic patients during Ramadan. Questions covered the recommended timing and dosing for metformin and insulin as well as the safe blood glucose range required for diabetic patients to safely continue their fast. Using logistic regression, a model was estimated to predict pharmacists’ willingness to attend a workshop on the adjustment of medication regimens during Ramadan. Content analysis was used to analyze pharmacists’ answers to the question concerning what they would like the workshop to cover. Main outcome measure Pharmacists’ aggregate scores for all three diabetes management knowledge questions and pharmacists’ willingness to attend a workshop on the adjustment of medication regimens during Ramadan. Results Ninety three percent of the 298 approached pharmacists agreed to participate. Forty three pharmacists (15.9 %) did not know the correct answer to any question, 118(43.7 %) 24 answered one correctly, 86 (31.9 %) answered two correctly and only 23 (8.5 %) answered all 25 three correctly. Confidence in therapeutic knowledge regarding medication regimen 26 adjustment during Ramadan was not associated with the pharmacists’ knowledge of diabetes management during Ramadan. One hundred seventy five (63.6 %) pharmacists wanted to attend a workshop on adjusting medication regimens during Ramadan. This was significantly associated with pharmacists being Muslim (OR 3.52, CI 1.70–7.27) and of younger age (OR 30 = 0.98, CI 0.96–0.99978). Pharmacists offered specific content and communication process 31 suggestions for the workshop content. Conclusion This study identifies variability among community pharmacists’ knowledge of diabetes management during Ramadan. It also shows willingness among the majority of pharmacists to learn more about the topic

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kettani H. World Muslim Population: 1950–2020. Int J Environ Sci Dev. 2010;1(2):127–70.

    Article  Google Scholar 

  2. Arafa N, Amin G. The epidemiology of diabetes mellitus in Egypt: Results of a National Survey. Egypt J Comm Med. 2010;28:29–43.

    Google Scholar 

  3. El-Zanaty F, Way A. Egypt demographic and health survey 2008. Cairo, Egypt: Ministry of Health, El-Zanaty and Associates, and Macro International; 2009.

    Google Scholar 

  4. Al-Mendalawi MD. Effects of Ramadan fasting on glucose levels and serum lipid profile among type 2 diabetic patients. Saudi Med J. 2011;32(6):647.

    PubMed  Google Scholar 

  5. Alberti H, Boudriga N, Nabli M. Lower attendance rates and higher fasting glucose levels in the month of Ramadan in patients with diabetes in a Muslim country. Diabet Med. 2008;25(5):637–8.

    Article  CAS  PubMed  Google Scholar 

  6. Chan F, Slater C, Syed AA. Diabetes and Ramadan. Fasts after bariatric surgery. BMJ. 2010;341:c3706.

    Article  PubMed  Google Scholar 

  7. Khaled BM, Belbraouet S. Effect of Ramadan fasting on anthropometric parameters and food consumption in 276 type 2 diabetic obese women. Int J Diabetes Dev Ctries. 2009;29(2):62–8.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Salman H, et al. Ramadan fasting in diabetic children in Riyadh. Diabet Med. 1992;9(6):583–4.

    Article  CAS  PubMed  Google Scholar 

  9. Al-Arouj M, et al. Recommendations for management of diabetes during Ramadan: Update 2010. Diabetes Care. 2010;33(8):1895–902.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Sifri AlS, et al. The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: A randomised trial. Int J Clin Pract. 2011;65(11):1132–40.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Bakiner O, et al. Repaglinide plus single-dose insulin glargine: A safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan. Acta Diabetol. 2009;46(1):63–5.

    Article  CAS  PubMed  Google Scholar 

  12. Bin-Abbas BS. Insulin pump therapy during Ramadan fasting in type 1 diabetic adolescents. Ann Saudi Med. 2008;28(4):305–6.

    Article  PubMed  Google Scholar 

  13. Hassanein M, et al. Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: Results of the VECTOR study. Curr Med Res Opin. 2011;27(7):1367–74.

    Article  CAS  PubMed  Google Scholar 

  14. Hui E, et al. Comparison of Humalog Mix 50 with human insulin Mix 30 in type 2 diabetes patients during Ramadan. Int J Clin Pract. 2010;64(8):1095–9.

    Article  CAS  PubMed  Google Scholar 

  15. Salti I. Diabetes, and G. Ramadan Study, Efficacy and safety of insulin glargine and glimepiride in subjects with Type 2 diabetes before, during and after the period of fasting in Ramadan. Diabet Med. 2009;26(12):1255–61.

    Article  CAS  PubMed  Google Scholar 

  16. Sari R, et al. The effects of diet, sulfonylurea, and Repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan. Endocr Res. 2004;30(2):169–77.

    Article  CAS  PubMed  Google Scholar 

  17. Zargar AH, et al. Maintenance of glycaemic control with the evening administration of a long acting sulphonylurea in male type 2 diabetic patients undertaking the Ramadan fast. Int J Clin Pract. 2010;64(8):1090–4.

    Article  CAS  PubMed  Google Scholar 

  18. Salti I, et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: Results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care. 2004;27(10):2306–11.

    Article  PubMed  Google Scholar 

  19. Almaatouq MA. Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan. Diabetes Metab Syndr Obes. 2012;5:109–19.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Mygind A, et al. Patient perspectives on type 2 diabetes and medicine use during Ramadan among Pakistanis in Denmark. Int J Clin Pharm. 2013;35(2):281–8.

    Article  PubMed  Google Scholar 

  21. Gaborit B, et al. Ramadan fasting with diabetes: An interview study of inpatients’ and general practitioners’ attitudes in the South of France. Diabetes Metab. 2011;37(5):395–402.

    Article  CAS  PubMed  Google Scholar 

  22. Peeters, B., et al. Ramadan fasting and diabetes: An observational study among Turkish migrants in Belgium. Prim Care Diabetes. 2012; p. 293–6.

  23. Taher A, Stuart EW, Hegazy I. The pharmacist’s role in the Egyptian pharmaceutical market. Int J Pharm Healthc Mark. 2012;6(2):140–55.

    Article  Google Scholar 

  24. Amin, M., Pharmacists’ Role in Adjusting Medication Regimens for Muslim Patients in Ramadan, University of Wisconsin-Madison: Madison, Wisconsin; 2013.

  25. Aadil N, Houti IE, Moussamih S. Drug intake during Ramadan. BMJ. 2004;329(7469):778–82.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Begum Y. GP guide to managing patients who wish to fast during Ramadan. Prescriber. 2011;22(13–14):14–21.

    Google Scholar 

  27. Bravis V, et al. Ramadan Education and Awareness in Diabetes (READ) programme for Muslims with Type 2 diabetes who fast during Ramadan. Diabet Med. 2010;27(3):327–31.

    Article  CAS  PubMed  Google Scholar 

  28. Hassanein MM. Diabetes and Ramadan: How to achieve a safer fast for Muslims with diabetes. Br J Diabetes Vasc Dis. 2010;10(5):246–50.

    Article  Google Scholar 

  29. Hui E, et al. Management of people with diabetes wanting to fast during Ramadan. BMJ. 2010;340:c3053.

    Article  CAS  PubMed  Google Scholar 

  30. Karamat MA, Syed A, Hanif W. Review of diabetes management and guidelines during Ramadan. J R Soc Med. 2010;103(4):139–47.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Qaisi VG. Increasing awareness of health care concerns during Ramadan. J Am Pharm Assoc (Wash). 2001;41(4):511.

    CAS  Google Scholar 

  32. Holdford D. Content analysis methods for conducting research in social and administrative pharmacy. Res Social Adm Pharm. 2008;4(2):173–81.

    Article  PubMed  Google Scholar 

  33. Wilbur, K., Al-Tawengi K, Remoden E, How do pharmacists advise diabetes patient self-management during the holy month of Ramadan?, in ISPOR 15th Annual European Conference. 2012: Berlin, Germany.

  34. Mohamed Ibrahim OH. Assessment of Egyptian pharmacists’ attitude, behaviors, and preferences related to continuing education. Int J Clin Pharm. 2012;34(2):358–63.

    Article  PubMed  Google Scholar 

  35. Amin ME, Chewning BA, Wahdan AM. Sources of drug information for patients with chronic conditions in Alexandria, Egypt. Int J Pharm Pract. 2011;19(1):13–20.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Dr. David Kreling, Dr. Nora Cate Schaeffer, Dr. Henry Young and Dr. Connie Kraus at the University of Wisconsin-Madison for their comments and suggestions which have been instrumental in shaping this project. The first author is thankful for the support received from the Joseph Wiederholt Wisconsin Distinguished Graduate Fellowship during the academic year 2012–2013.

Funding

This research was supported by a dissertator grant award provided by the Sonderegger Research Center at the School of Pharmacy, University of Wisconsin-Madison.

Conflicts of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Joseph Wiederholt Wisconsin Distinguished Graduate Fellow, School of Pharmacy, University of Wisconsin-Madison, 2503 Rennebohm Hall, 777 Highland Avenue, Madison, WI, 53705-2222, USA

    Mohamed E. K. Amin

  2. Sonderegger Research Center, School of Pharmacy, University of Wisconsin-Madison, 2523 Rennebohm Hall, 777 Highland Avenue, Madison, WI, 53705-2222, USA

    Betty Chewning

Authors
  1. Mohamed E. K. Amin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Betty Chewning
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohamed E. K. Amin.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amin, M.E.K., Chewning, B. Community pharmacists’ knowledge of diabetes management during Ramadan in Egypt. Int J Clin Pharm 36, 1213–1221 (2014). https://doi.org/10.1007/s11096-014-0019-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-014-0019-6

Keywords

Search

Navigation